课题基金 / 基金详情

The mechanism of immune insufficiency against retroviral tumors and its restoration

The mechanism of immune insufficiency against retroviral tumors and its restoration
逆转录病毒肿瘤免疫功能低下的机制及其修复
批准号:
15023217
负责人:
KANNAGI Mari
金额:
$10.94万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

KANNAGI Mari的其他基金

相似基金

相关文献

中文摘要
翻译
已经注意到,成人T细胞白血病(ATL)偶然与母婴感染有关,主要通过母乳建立。在我们的大鼠系统中,口服感染的大鼠表现出显着更高水平的持续性人类T细胞白血病病毒I型(HTLV-I)的负载和更弱的免疫反应,HTLV-I比腹腔感染的大鼠。因此,持续的病毒载量与病毒特异性T细胞应答水平呈负相关。然而,经口感染大鼠的免疫应答不足可以通过皮下重新免疫适当的抗原来恢复。我们还研究了ATL患者的细胞免疫应答,这些患者在来自HLA相同的同胞供体的非清髓性异基因外周血造血干细胞移植(HSCT)后获得完全缓解,并且发现HTLV-I Tax特异性CTL应答在这些患者中的一些患者中在HSCT后而不是HSCT前被强烈激活。这些研究结果表明,在原发性HTLV-I感染时建立的HTLV-I特异性免疫功能不全可能是ATL发展的潜在风险因素,但可以通过免疫策略克服。
英文摘要
It has been noted that adult T-cell leukemia (ATL) is incidentally associated with mother-to-child infection, mostly established via mother milk. In our rat system, orally infected rats exhibited significantly higher levels of persistent human T-cell leukemia virus type I (HTLV-I) load and much weaker immune response to HTLV-I than that in intraperitoneally infected rats. As a result, persistent viral load was inversely correlated with levels of virus-specific T-cell responses. The insufficient immune responses in orally infected rats could be, however, recovered by subcutaneous re-immunization with appropriate antigens. We also investigated cellular immune responses of ATL patients who obtained complete remission following non-myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling donors, and found that HTLV-I Tax-specific CTL response was strongly activated in some of these patients post-HSCT but not before HSCT. These findings suggest that HTLV-I-specific immune insufficiency established at primary HTLV-I infection may be an underlying risk factor for development of ATL, but could be overcome with immunological strategies.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
H.Liu, T.Ohashi, T.Masuda.X.Zhou, M.Kubo, M.Kannagi: "Suppression of HIV-I replication by HIV-I-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-I-infected cells in vitro."Viral Immunology. 16. 381-393 (2003)
H.Liu、T.Ohashi、T.Masuda.X.Zhou、M.Kubo、M.Kannagi:“通过与 HIV-1 无关的 CD8 细胞毒性 T 淋巴细胞抑制 HIV-1 复制,导致持续保存 HIV-1-
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1002/ijc.20737
发表时间: 2005-03-20
期刊: INTERNATIONAL JOURNAL OF CANCER
影响因子: 6.4
作者: [Kurihara, K, Harashima, N, Kannagi, M]
通讯作者: Kannagi, M
Future prophylaxis and immunotherapy for adult T cell leukemia.
成人 T 细胞白血病的未来预防和免疫治疗。
DOI: --
发表时间: 2004
期刊: Expert Review of Anticancer Therapy 4
影响因子: --
作者: [M.Kannagi, et al.]
通讯作者: et al.
Correlation of major hi stocompatibi1ity complex class I downregulation with resistance of human T cell leukemia virus type I-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
在大鼠模型中,主要组织相容性复合体 I 类下调与人 T 细胞白血病病毒 I 型感染的 T 细胞对细胞毒性 T 淋巴细胞杀伤的抵抗力的相关性。
DOI: --
发表时间: 2002
期刊: J.Virol. 76
影响因子: --
作者: [T.Ohashi, S.Hanabuchi, R.Suzuki, H.Kato, H.Tateno, T.Masuda, M.Kannagi.]
通讯作者: M.Kannagi.
共 15 条
    Host innate immune mechanisms separating inflammatory or lymphoproliferative diseases in HTLV-1 infection
    Anti-viral immuno therapeutic approaches for adult T-cell leukemia
    • 批准号:
      17013028
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $31.04万
    • 财政年份:
      2005
    • 负责人:
      KANNAGI Mari
    • 依托单位:
    Role of vertical transmission of HTLV-I on the risk for T cell malignancy
    • 批准号:
      12470052
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.91万
    • 财政年份:
      2000
    • 负责人:
      KANNAGI Mari
    • 依托单位:
    Spontaneous inhibition of HTL V-I expression in the peripheral blood
    海外基金